Philips Receives FDA Clearance for Rembra CT Imaging Platform

Royal Philips has received FDA 510(k) clearance for its Rembra platform, which includes Rembra CT, Rembra RT, and Areta RT systems, aimed at enhancing the speed and precision of CT imaging for frontline care and cancer treatment planning. The Rembra platform is designed to meet the increasing demand for imaging and radiation therapy, providing advanced capabilities to streamline workflows and support confident clinical decisions.